BBIO
BridgeBio Pharma Inc
66.30$
+0.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +374.2% | +35.9% | +11.4% | +43.9% | -38.5% | -12.3% | +68.3% | +1.8% | |
| – | +358.4% | +27.7% | +13.0% | +38.3% | -38.3% | -13.0% | +50.9% | +4.6% | |
| – | +374.0% | -16.6% | -2.1% | +10.6% | -4.3% | -0.2% | +81.2% | -16.3% | |
| – | +374.0% | +25.2% | +11.2% | +37.8% | -43.6% | -7.8% | +56.6% | -13.7% | |
| – | – | – | – | – | -13.5% | -89.7% | +169.7% | +2,853.1% | |
| – | – | – | – | – | – | -56.1% | -100.0% | – | |
| – | +258.0% | +257.1% | +261.3% | +126.2% | -68.3% | – | – | – | |
| – | – | – | – | – | -36.1% | -8.3% | -9.1% | +17.3% | |
| – | +270.9% | -72.5% | +282.6% | +215.3% | -0.6% | +1.1% | +25.8% | +26.7% | |
| – | +281.0% | +85.4% | +58.4% | +41.2% | -10.1% | +18.5% | +7.3% | +86.5% | |
| – | – | – | -34.3% | -6.0% | -25.6% | +12.3% | +9.2% | +286.4% | |
| – | +616.7% | -34.5% | +1.1% | +32.9% | -2.7% | -7.8% | -9.7% | +276.7% | |
| – | – | +68.4% | +418.4% | +258.0% | +0.2% | +1.1% | -0.3% | +7.6% | |
| – | – | – | -85.8% | -1,603.1% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +13.8% | +12.3% | +22.3% | +2.2% | +10.4% | +14.3% | +6.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.